Prognostic significance of prognostic nutritional index in high-grade serous ovarian cancer: a comparative analysis with other prognostic factors
Open Access
- 30 June 2025
- journal article
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (2) , 519-529
Abstract
Purpose: High-grade serous ovarian cancer (HGSOC) has high recurrence and mortality rates despite treatment advances. The prognostic nutritional index (PNI) shows promise in other cancers, but its role in HGSOC is unclear. This study aimed to evaluate PNI's prognostic value in HGSOC and establish an optimal cutoff for mortality prediction. Materials and Methods: This retrospective cohort evaluated 332 patients with HGSOC from 2010-2020. The age range, body mass index (BMI), menopausal status, parity status, presence of comorbidities, American Society of Anesthesiologists (ASA) scores, the presence of ascites, cancer antigen 125 (CA-125), neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, disease stage, recurrence status, platinum resistance, attainment of optimal cytoreduction, and PNI were evaluated. PNI relationship with other factors affecting prognosis was evaluated. Results: The Mean PNI was 41.8±8.7, with a cutoff of ≤44.6 (96.84% sensitivity, 81.69% specificity) for mortality prediction. PNI was a stronger predictor (AUC=0.932) than CA-125 (AUC=0.588). Low PNI (≤44.6) was significantly linked with advanced disease, platinum resistance, preoperative ascites ≥ 1 L, more recurrences, lower 5-year survival, and higher mortality. Multivariate analysis showed low PNI as an independent mortality predictor (OR: 136.82, 95% CI: 54.6-342.4), along with preoperative ascites > 1 L and disease recurrence. Conclusion: A low preoperative PNI strongly predicts higher mortality in HGSOC patients than in CA-125 patients. This accessible and cost-effective biomarker may aid in assessing risks, guiding increased monitoring, and customizing treatments. Further studies are necessary to confirm these results in various populations.Keywords
This publication has 22 references indexed in Scilit:
- Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trialThe Lancet Oncology, 2023
- The Prognostic Value of Prognostic Nutritional Index in Patients with Ovarian Cancer: A Systematic Review and Meta-AnalysisNutrition and Cancer, 2022
- Prognostic significance of preoperative prognostic nutritional index in ovarian cancerMedicine, 2020
- Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancerInternational Journal of Gynecological Cancer, 2019
- Epithelial ovarian cancerThe Lancet, 2019
- Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective studyGynecologic Oncology, 2019
- Preoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancerScientific Reports, 2017
- Prognostic Significance of Preoperative Prognostic Nutritional Index in Epithelial Ovarian Cancer Patients Treated with Platinum-Based ChemotherapyOncology Research and Treatment, 2016
- Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patientsThe American Journal of Clinical Nutrition, 2008
- Ascites as a Predictor of Ovarian MalignancyGynecologic Oncology, 2002